Morgan Stanley »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Morgan Stanley

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $12M 10M 1.14
2024-12-31 $11M 9.8M 1.08
2024-09-30 $12M 10M 1.19
2024-06-30 $10M 9.2M 1.11
2024-03-31 $9.0M 9.2M 0.97
2023-12-31 $9.6M 10M 0.93
2023-09-30 $9.3M 10M 0.93

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1